Last reviewed · How we verify
NCT07007585: DENGUE-FACT
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
trial in Dengue in 100 participants. Currently enrolling.
31 July 2028
Quick facts
| Lead sponsor | Jose Ivan Rodriguez de Molina Serrano |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 August 2025 |
| Primary completion | 31 July 2028 |
| Estimated completion | 30 August 2028 |
| Sites | 1 location across Mexico |
Conditions studied
- Dengue — all drugs for Dengue →
- Dengue Fever — all drugs for Dengue Fever →
- Dengue Fever With Warning Signs — all drugs for Dengue Fever With Warning Signs →
Sponsor
Jose Ivan Rodriguez de Molina Serrano
Who can join
5 and older, any sex, with Dengue or Dengue Fever. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07007585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dengue
Currently open trials in the same condition.
- NCT07501793 — Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam · active not recruiting
- NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
- NCT06894901 — Impact of IIT-SIT on Dengue Clusters · NA · recruiting
- NCT07158190 — Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda). · active not recruiting
- NCT06599970 — Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility · recruiting
Other Jose Ivan Rodriguez de Molina Serrano trials
Trials by the same sponsor.
- NCT07004790 — Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. Th · NA · not yet recruiting
- NCT04193254 — LPP , MP and DP:Relation With Mortality and SOFA in Mechanically Ventilated Patients in ER, Ward and ICU · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07007585 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jose Ivan Rodriguez de Molina Serrano
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07007585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing